Financial News

Date Title and Summary Additional Formats
Toggle Summary ViewRay Announces Participation in the B. Riley Oncology Investor Conference
CLEVELAND , Jan. 15, 2021 /PRNewswire/ --  ViewRay, Inc. (NASDAQ: VRAY) (the "Company") today announced that members of management will be participating in a fireside chat at the B. Riley Oncology Investor Conference on Wednesday, January 20, 2021 . ViewRay will also be hosting 1x1 meetings with
Toggle Summary ViewRay to Present at the 39th Annual J.P. Morgan Healthcare Conference
CLEVELAND , Dec. 23, 2020 /PRNewswire/ -- ViewRay, Inc. (NASDAQ: VRAY) today announced its participation in the 39th Annual J.P. Morgan Healthcare Conference . Scott Drake , President and CEO, is scheduled to present at 10:50 a.m. Eastern Time on Thursday, January 14, 2021 .
Toggle Summary ViewRay Announces Full Exercise of Underwriters' Option to Purchase Additional Shares and Closing of Public Offering of Common Stock
CLEVELAND , Jan. 7, 2021 /PRNewswire/ -- ViewRay, Inc. (Nasdaq: VRAY), maker of the MRIdian, which combines MRI and external-beam radiation therapy to simultaneously image and treat cancer patients, today announced the completion of its previously announced underwritten public offering of
Toggle Summary ViewRay Announces Pricing of Public Offering of Common Stock
CLEVELAND , Jan. 4, 2021 /PRNewswire/ --  ViewRay, Inc. (Nasdaq: VRAY), maker of the MRIdian, which combines MRI and external-beam radiation therapy to simultaneously image and treat cancer patients, today announced the pricing of an underwritten public offering of 10,310,000 shares of common stock
Toggle Summary ViewRay Announces Proposed Public Offering of Common Stock
CLEVELAND , Jan. 4, 2021 /PRNewswire/ --  ViewRay, Inc. (Nasdaq: VRAY), maker of the MRIdian, which combines MRI and external-beam radiation therapy to simultaneously image and treat cancer patients, today announced that it has commenced an underwritten public offering of shares of its common
Toggle Summary ViewRay Announces Preliminary Fourth Quarter and Full Year 2020 Results
CLEVELAND, Ohio , Jan. 4, 2021 /PRNewswire/ --  ViewRay, Inc. (NASDAQ: VRAY) today announced preliminary results for the fourth quarter and full fiscal year ended December 31, 2020 . The preliminary results have not been audited and are subject to change.
Toggle Summary Seoul National University Hospital Treats 1,000th Patient with MRIdian MRI-Guided Radiation Therapy
Leading Healthcare Facility in South Korea Helps Advance the Practice of MRI-Guided Radiation Therapy Through Research, Protocols, and Publications CLEVELAND , Dec. 22, 2020 /PRNewswire/ --  ViewRay, Inc. (Nasdaq: VRAY) announced today that the clinical team at Seoul National University Hospital
Toggle Summary Eindhoven's Catharina Hospital Purchases ViewRay's MRIdian Linac
Leading Clinical Training Hospital Aims to Begin MRIdian Patient Treatments in 2021 CLEVELAND , Dec. 21, 2020 /PRNewswire/ --  ViewRay, Inc. (Nasdaq: VRAY) announced today that Catharina Hospital in Eindhoven, Netherlands , also known as Catharina Ziekenhuis, has purchased a MRIdian ® Linac
Toggle Summary ViewRay to Present at the Piper Sandler 32nd Annual Virtual Healthcare Conference
CLEVELAND , Nov. 23, 2020 /PRNewswire/ -- ViewRay, Inc. (NASDAQ: VRAY) today announced its participation in the Piper Sandler 32nd Annual Virtual Healthcare Conference .     From November 23 to December 3, 2020 , a fireside chat recording will be available for registered attendees via the Piper
Toggle Summary Amsterdam University Medical Centers Treats 1,000th Patient with MRIdian SMART MRI-Guided Radiation Therapy
Amsterdam UMC reaches treatment milestone while establishing key clinical evidence in tough-to-treat cancer including pancreas, prostate, lung, liver, and kidney CLEVELAND , Nov. 12, 2020 /PRNewswire/ --  ViewRay, Inc. (Nasdaq: VRAY) announced today that the clinical team at Amsterdam University
Toggle Summary Leading Academic Clinical Training Hospital, Universitair Ziekenhuis Brussels, Purchases ViewRay's MRIdian Linac
Universitair Ziekenhuis Brussels in Belgium Aims to Begin MRIdian Patient Treatments in 2021 CLEVELAND , Nov. 10, 2020 /PRNewswire/ -- ViewRay, Inc. (Nasdaq: VRAY) announced today that Universitair Ziekenhuis Brussels has purchased a MRIdian ®  Linac MRI-Guided Therapy System, a cutting-edge
Toggle Summary ViewRay Reports Third Quarter 2020 Results
CLEVELAND , Nov. 5, 2020 /PRNewswire/ --  ViewRay, Inc. (Nasdaq: VRAY) (the "Company") today announced financial results for the third quarter ended September 30, 2020 .     Third Quarter 2020 Highlights: Total revenue of $10.1 million , primarily from one revenue unit, compared to $20.9 million ,
Toggle Summary ASTRO 2020 to Feature Latest MRIdian Clinical Experience Highlighting Outcomes in Tough to Treat Cancer
Nearly 40 MRIdian-focused presentations will be part of the ASTRO Scientific Sessions CLEVELAND , Oct. 21, 2020 /PRNewswire/ --  ViewRay, Inc. (Nasdaq: VRAY) announced today that the company's MRIdian® Linac MRI-guided radiation therapy system will be featured at the 2020 Annual Meeting of the
Toggle Summary ViewRay Announces Conference Call for Third Quarter 2020 Financial Results to be Held After Market on November 5, 2020
CLEVELAND , Oct. 15, 2020 /PRNewswire/ -- ViewRay, Inc. (Nasdaq: VRAY) announced today details relating to the release of its third quarter 2020 financial results.     ViewRay will hold a conference call to discuss results on Thursday, November 5, 2020 at 4:30 p.m. ET / 1:30 p.m. PT .
Toggle Summary Louis Stokes Cleveland VA Medical Center Purchases ViewRay's MRIdian Linac for MRI-Guided Radiation Therapy
MRIdian to Bring Benefits of MRI-Guided Radiation Therapy to Veterans Throughout Ohio and the Surrounding Region CLEVELAND , Oct. 14, 2020 /PRNewswire/ --  ViewRay, Inc. (Nasdaq: VRAY) announced today that the Louis Stokes Cleveland VA Medical Center in Cleveland, Ohio has purchased the MRIdian ®
Toggle Summary ViewRay to Host Physician-led Webinar for Investors and Analysts at the 2020 American Society of Radiation Oncology (ASTRO) Annual Meeting
CLEVELAND , Oct. 1, 2020 /PRNewswire/ --  ViewRay, Inc. (Nasdaq: VRAY) today announced that the Company will host a virtual physician-led informational discussion for investors and analysts during the 2020 American Society of Radiation Oncology (ASTRO) Annual Meeting.
Toggle Summary Chungnam National University Sejong Hospital Begins Patient Treatments with ViewRay's MRIdian Linac
Brings Benefits of MRI-Guided Radiation Therapy Closer to Home for Cancer Patients in Korea CLEVELAND , Sept. 24, 2020 /PRNewswire/ --  ViewRay, Inc. (Nasdaq: VRAY) announced today that Chungnam National University Sejong Hospital in Sejong, South Korea has begun patient treatments with the MRIdian
Toggle Summary ViewRay® to Participate in Upcoming Investor Conferences
CLEVELAND , Sept. 4, 2020 /PRNewswire/ -- ViewRay, Inc. (NASDAQ: VRAY) today announced that the Company will participate in three upcoming virtual investor conferences.     Event :             Cantor Virtual Global Healthcare Conference   Format:   Virtual 1x1 Meetings Date:               
Toggle Summary 10,000th Patient Receives Treatment with ViewRay's MRIdian System
MRI-Guided Radiation Therapy Brings Cutting-Edge Cancer Treatment to Patients Around the World CLEVELAND , Sept. 1, 2020 /PRNewswire/ --  ViewRay, Inc. (Nasdaq: VRAY) announced today that 10,000 patients have been treated to date using the company's MRIdian ® MRI-Guided Radiation Therapy System,
Toggle Summary ViewRay, GenesisCare and the University of Oxford Announce Groundbreaking Compassionate Access Programme Now Open to UK Patients with Localized Pancreatic Cancer
ViewRay, the GenesisCare Foundation and the Pancreatic Cancer Research Fund Work Together to Provide MRIdian Radiation Therapy at No Cost to NHS Pancreatic Cancer Patients CLEVELAND , Aug. 27, 2020 /PRNewswire/ --– ViewRay, Inc. (Nasdaq: VRAY) announced today that the GenesisCare Foundation's

Stock Quote

Data Provided by Refinitiv. Minimum 15 minutes delayed.

E-mail Alerts

Alerts are e-mailed to you whenever certain new company information is posted to this site. Sign-up Now!
Click here for E-mail Alerts

Transfer Agent
American Stock Transfer & Trust Company, LLC
6201 15th Avenue
Brooklyn, NY 11219
(800) 937-5449
Website: www.amstock.com
Email: info@amstock.com

In Need of Customer Support? Contact

  Language Select